505 results on '"Simbrunner, Benedikt"'
Search Results
2. Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcome
3. Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure
4. Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response
5. Prognostic performance of non-invasive tests for portal hypertension is comparable to that of hepatic venous pressure gradient
6. The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation
7. Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension
8. Inhibition of the renal apical sodium dependent bile acid transporter prevents cholemic nephropathy in mice with obstructive cholestasis
9. Diagnostic and prognostic performance of the LiverRisk score in tertiary care
10. Lower free triiodothyronine (fT3) levels in cirrhosis are linked to systemic inflammation, higher risk of acute-on-chronic liver failure, and mortality
11. Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD
12. Low mortality despite temporary liver dysfunction in severe courses of acute hepatitis E
13. Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder
14. Dynamics in Liver Stiffness Measurements Predict Outcomes in Advanced Chronic Liver Disease
15. The impact of transmembrane 6 superfamily 2 (TM6SF2) rs58542926 on liver-related events in patients with advanced chronic liver disease
16. An impaired pituitary–adrenal signalling axis in stable cirrhosis is linked to worse prognosis
17. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis
18. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis
19. The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal Hypertension
20. Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis
21. Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity
22. Dysregulated biomarkers of innate and adaptive immunity predict infections and disease progression in cirrhosis
23. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease
24. Inter- and intra-reader agreement for gadoxetic acid–enhanced MRI parameter readings in patients with chronic liver diseases
25. Characterization of a prothrombotic phenotype using thrombin generation and thrombin activity in cirrhosis and portal hypertension
26. Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis
27. TOP-097-YI Dynamics of systemic inflammation after TIPS implantation and their impact on acute-on-chronic liver failure and liver-related death
28. FRI-009-YI Diagnostic and prognostic performance of the LiverRisk score in tertiary care
29. SAT-105 Neutrophil extracellular traps are not linked to the development of decompensation, ACLF, or death in clinically stable patients with advanced chronic liver disease
30. WED-171 Spleen stiffness and VWF-based non-invasive tests reflect severity of prehepatic and presinusoidal portal hypertension
31. THU-075-YI Incidence and prognostic value of zinc and seleniumdeficiency in cirrhosis
32. LBP-016 Carvedilol versus propranolol in the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis
33. SAT-086-YI Assessment of portal hypertension risk by liver and spleen stiffness using real-time 2D-shear wave elastography-the prospective AiXplore study
34. SAT-128 Circulating fibronectin levels are linked to endothelial dysfunction, fibrogenesis, and portal hypertension in advanced chronic liver disease
35. SAT-106 Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) predicts acute-on-chronic liver failure in patients with acute decompensation
36. WED-089-YI Characterising the hemodynamic and pro-inflammatory profile of a CCl4/LPS-induced acute-on-chronic liver failure (ACLF) rat model
37. SAT-111 Lower levels of Insulin-like growth factor 1 are independently associated with unfavorable prognosis in patients with advanced chronic liver disease
38. THU-540 Characterization of in vivo mouse models of regressive fibrosis and resolving portal hypertension
39. THU-071 Impact of underlying portal hypertension and systemic inflammation on acute-on-chronic liver failure (ACLF) severity and outcome
40. WED-125 Differential regulation of soluble guanylate cyclase signaling during liver fibrosis regression
41. Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply
42. Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
43. Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver disease
44. Gadoxetic acid-enhanced MRI-derived functional liver imaging score (FLIS) and spleen diameter predict outcomes in ACLD
45. Angiopoietin 2 levels decrease after HCV-cure and reflect the evolution of portal hypertension
46. Decreasing von Willebrand Factor Levels Upon Nonselective Beta Blocker Therapy Indicate a Decreased Risk of Further Decompensation, Acute-on-chronic Liver Failure, and Death
47. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices
48. Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis
49. Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension
50. High histamine levels are associated with acute‐on‐chronic liver failure and liver‐related death in patients with advanced chronic liver disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.